---
document_datetime: 2023-09-21 20:44:37
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/ovitrelle-epar-all-authorised-presentations_en.pdf
document_name: ovitrelle-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.7328794
conversion_datetime: 2025-12-24 17:32:07.522775
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | Invented name   | Strength      | Pharmaceutical form                      | Route of administration   | Immediate packaging                           | Content   | Pack size                    |
|------------------|-----------------|---------------|------------------------------------------|---------------------------|-----------------------------------------------|-----------|------------------------------|
| EU/1/00/165/007  | Ovitrelle       | 250 µg/0.5 mL | Solution for injection                   | Subcutaneous use          | pre-filled syringe (glass)                    | 0.5 mL    | 1 pre-filled syringe         |
| EU/1/00/165/008  | Ovitrelle       | 250 µg        | Solution for injection in pre-filled pen | Subcutaneous use          | Cartridge in a pre-filled pen (250 µg/0.5 mL) | 0.5 mL    | 1 pre-filled pen + 2 needles |